| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Catalpol | Atherosclerosis | 1 | PM | 34326774 | 📋 | Research Progress on Catalpol as Treatment for Atherosclerosis |
| Catalpol | Atherosclerosis | 2 | PM | 33995075 | 📋 | Catalpol Inhibits Macrophage Polarization and Prevents Postmenopausal Atherosclerosis Through Regulating Estrogen Receptor Alpha |
| Catalpol | Blood-Brain Barrier Permeability | 1 | PM | 36369944 | 📋 | Catalpol relieved angiotensin II-induced blood-brain barrier destruction via inhibiting the TLR4 pathway in brain endothelial cells |
| Catalpol | Cardiotoxicity | 1 | PM | 37778994 | 📋 | Catalpol Inhibits Autophagy to Ameliorate Doxorubicin-Induced Cardiotoxicity via the AKT-mTOR Pathway |
| Catalpol | Cardiovascular Disease | 1 | PM | 38024856 | 📋 | Protective effects of catalpol on cardio-cerebrovascular diseases: A comprehensive review |
| Catalpol | Cerebral Ischemia | 2 | PM | 35115763 | 📋 | Feasibility of Catalpol Intranasal Administration and Its Protective Effect on Acute Cerebral Ischemia in Rats via Anti-Oxidative and Anti-Apoptotic Mechanisms |
| Catalpol | Cerebral Ischemia | 1 | PM | 34586619 | 📋 | Protective Effects of Catalpol on Limb Motor Function and Ultrastructure of Hippocampal Neurons in Rats with Cerebral Ischemia |
| Catalpol | Cerebrovascular Disease | 2 | PM | 38024856 | 📋 | Protective effects of catalpol on cardio-cerebrovascular diseases: A comprehensive review |
| Catalpol | Cerebrovascular Disease | 1 | PM | 34326774 | 📋 | Research Progress on Catalpol as Treatment for Atherosclerosis |
| Catalpol | Endothelial Dysfunction | 1 | PM | 34416245 | 📋 | Catalpol ameliorates endothelial dysfunction and inflammation in diabetic nephropathy via suppression of RAGE/RhoA/ROCK signaling pathway |
| Catalpol | Hepatic Ischemia-Reperfusion | 1 | PM | 37979473 | 📋 | Catapol attenuates the aseptic inflammatory response to hepatic I/R injury in vivo and in vitro by inhibiting the HMGB1/TLR-4/NF-κB signaling pathway via the microRNA-410-3p |
| Catalpol | Ischemic Stroke | 3 | PM | 38522312 | 📋 | Catalpol attenuates ischemic stroke by promoting neurogenesis and angiogenesis via the SDF-1α/CXCR4 pathway |
| Catalpol | Ischemic Stroke | 2 | PM | 37439957 | 📋 | Catalpol Alleviates Ischemic Stroke Through Promoting Angiogenesis and Facilitating Proliferation and Differentiation of Neural Stem Cells via the VEGF-A/KDR Pathway |
| Catalpol | Ischemic Stroke | 1 | PM | 34795412 | 📋 | Catalpol improves impaired neurovascular unit in ischemic stroke rats via enhancing VEGF-PI3K/AKT and VEGF-MEK1/2/ERK1/2 signaling |
| Catalpol | Myocardial Hypoxia | 1 | PM | 35307895 | 📋 | Catalpol protects AC16 cells from hypoxia/reoxygenation injury by regulating the miR-22-3p/DPP4 axis |
| Catalpol | Myocardial Ischemia-Reperfusion | 1 | PM | 34919942 | 📋 | Catalpol alleviates myocardial ischemia reperfusion injury by activating the Nrf2/HO-1 signaling pathway |
| Catalpol | Stroke | 1 | PM | 33505489 | 📋 | Network Pharmacology-Based Prediction of Catalpol and Mechanisms against Stroke |
